Dominic Lenz
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (11)
Among genetic disorders of vesicular trafficking, there are three causing recurrent acute liver failure (RALF): NBAS, RINT1, and SCYL1‐associated disease. These three disorders are characterized by liver crises triggered by febrile infections and account for a relevant proportion of RALF causes. While the frequency and severity of liver crises in NBAS and RINT1‐associated disease decrease with age, patients with SCYL1 variants present with a progressive, cholestatic course. In all three diseases, there is a multisystemic, partially overlapping phenotype with variable expression, including liver, skeletal, and nervous systems, all organ systems with high secretory activity. There are no specific biomarkers for these diseases, and whole exome sequencing should be performed in patients with RALF of unknown etiology. NBAS, SCYL1, and RINT1 are involved in antegrade and retrograde vesicular trafficking. Pathomechanisms remain unclarified, but there is evidence of a decrease in concentration and stability of the protein primarily affected by the respective gene defect and its interaction partners, potentially causing impairment of vesicular transport. The impairment of protein secretion by compromised antegrade transport provides a possible explanation for different organ manifestations such as bone alteration due to lack of collagens or diabetes mellitus when insulin secretion is affected. Dysfunction of retrograde transport impairs membrane recycling and autophagy. The impairment of vesicular trafficking results in increased endoplasmic reticulum stress, which, in hepatocytes, can progress to hepatocytolysis. While there is no curative therapy, an early and consequent implementation of an emergency protocol seems crucial for optimal therapeutic management.
Year:
2024
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (17)
Tian sun
Heidelberg University
Michael Huber
Head Diagnostics and Development
University of Zurich
Sebastian Hiller
University of Basel
Georg-Friedrich Vogel
Medical University of Innsbruck
Stefano Vavassori
Chief Operating Officer
metaLead Therapeutics AG
Chris Mühlhausen
Vice Director and Professor of Pediatrics
Universitätsmedizin Göttingen
Erik Eklund
Associate professor, chief physician
Region Skåne
Barbara Brotschi
University Children's Hospital Zurich
Tayfun Güngör
University of Zurich
John Neidhardt
Full Prof.
University of Oldenburg
Marcella Zollino
Università Cattolica del Sacro Cuore
Michael Gabbett
Queensland University of Technology
Mark Corbett
-
Adelheid Cerwenka
-
Elodie M. Richard
-
Philip Bufler
-
Agnieszka Nadel
Institute of Human Genetics
Make your next move.
Prepare your application
Review drafts before you send them.